Molecular mechanisms governing the action of the epidermal growth factor receptor and receptor tyrosine kinases, a personal perspective

I have been studying the mechanism of action of epidermal growth factor (EGF) receptor (EGFR), other receptor tyrosine kinases (RTKs) and their cellular signalling pathways for the past 45 years. A decade ago, I authored a review detailing the first two decades of research and highlighting critical milestones in this field (Cold Spring Harb. Perspect. Biol. 6, a008912 (2014) (doi:10.1101/cshperspect.a008912)). In the present article, I offer a personal perspective first on why and how I became interested in exploring the mechanism of action of EGF, and later about deciphering the modes of action of EGFR and other RTKs. These insights have also been pivotal in advancing the development of novel therapeutics. This article is part of the discussion meeting issue 'Epidermal growth factor receptor after 40 years'.

Authors

Institutions

Publication Details

Journal
Philosophical Transactions of the Royal Society B Biological Sciences
Published
2026-08-27
DOI
https://doi.org/10.1098/rstb.2024.0498
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular mechanisms governing the action of the epidermal growth factor receptor and receptor tyrosine kinases, a personal perspective

Joseph Schlessinger
Philosophical Transactions of the Royal Society B Biological Sciences
HER2/EGFR in Cancer Research
article

Molecular mechanisms governing the action of the epidermal growth factor receptor and receptor tyrosine kinases, a personal perspective

Joseph Schlessinger
article en

Abstract

I have been studying the mechanism of action of epidermal growth factor (EGF) receptor (EGFR), other receptor tyrosine kinases (RTKs) and their cellular signalling pathways for the past 45 years. A decade ago, I authored a review detailing the first two decades of research and highlighting critical milestones in this field (Cold Spring Harb. Perspect. Biol. 6, a008912 (2014) (doi:10.1101/cshperspect.a008912)). In the present article, I offer a personal perspective first on why and how I became interested in exploring the mechanism of action of EGF, and later about deciphering the modes of action of EGFR and other RTKs. These insights have also been pivotal in advancing the development of novel therapeutics. This article is part of the discussion meeting issue 'Epidermal growth factor receptor after 40 years'.

Philosophical Transactions of the Royal Society B Biological SciencesVol. 381(1957)
Yale University (US)
Openalex Percentile: Top 13%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.